Jubilant Pharmova Reports 49% Increase In Profit After Tax To Rs 103 crore

Jubilant Pharmova Reports 49% Increase In Profit After Tax To Rs 103 crore

The company said the reported PAT in Q1 of FY25 stood at Rs 482 crore due to one-time net exceptional income of Rs 396 crore

PTIUpdated: Tuesday, July 29, 2025, 03:05 PM IST
article-image
File Image |

New Delhi:Jubilant Pharmova on Tuesday reported a 49 per cent increase in profit after tax to Rs 103 crore for the first quarter ended June 30, 2025.The company reported a normalised profit after tax PAT of Rs 69 crore in the June quarter of the last fiscal.

The company said the reported PAT in Q1 of FY25 stood at Rs 482 crore due to one-time net exceptional income of Rs 396 crore.Revenue from operations rose to Rs 1,901 crore in the April-June quarter as compared with Rs 1,732 crore in the year-ago period, Jubilant Pharmova said in a regulatory filing.

"It is heartening to note that we delivered solid revenue growth across all of our business units, and we expect this growth momentum to grow stronger as we move forward," Jubilant Pharmova Chairman Shyam S Bhartia said.Jubilant Pharmova shares were trading 1.88 per cent down at Rs 1,151.70 apiece on BSE. 

Disclaimer: This story is from the syndicated feed. Nothing has changed except the headline.

RECENT STORIES

Rupee Hits Record Low Of 90.87 Against Dollar Amid FII Outflows, India-US Trade Deal Uncertainty

Rupee Hits Record Low Of 90.87 Against Dollar Amid FII Outflows, India-US Trade Deal Uncertainty

EaseMyTrip Promoter Nishant Pitti Pledges 18.94 Crore Shares To MOFSL

EaseMyTrip Promoter Nishant Pitti Pledges 18.94 Crore Shares To MOFSL

360 One Asset Raises ₹2,300 Crore Real Estate Fund, Deploys Majority In Key Projects

360 One Asset Raises ₹2,300 Crore Real Estate Fund, Deploys Majority In Key Projects

HRS Aluglaze IPO Oversubscribed 44.9 Times On Final Day, Non-Institutional Investors Take The Lead

HRS Aluglaze IPO Oversubscribed 44.9 Times On Final Day, Non-Institutional Investors Take The Lead

Sensex, Nifty Slide, Early Selling Pressure & Negative Cues From Asian Markets Drag

Sensex, Nifty Slide, Early Selling Pressure & Negative Cues From Asian Markets Drag